Biblio
] , “Tau Conformation as a Target for Disease-Modifying Therapy: The Role of Truncation.”, J Alzheimers Dis, vol. 64, no. s1, pp. S535-S546, 2018.
, “Changes of Cerebrospinal Fluid Peptides due to Tauopathy.”, J Alzheimers Dis, vol. 58, no. 2, pp. 507-520, 2017.
, “Neuronal Expression of Truncated Tau Efficiently Promotes Neurodegeneration in Animal Models: Pitfalls of Toxic Oligomer Analysis.”, J Alzheimers Dis, vol. 58, no. 4, pp. 1017-1025, 2017.
, “Human Truncated Tau Induces Mature Neurofibrillary Pathology in a Mouse Model of Human Tauopathy.”, J Alzheimers Dis, vol. 54, no. 2, pp. 831-43, 2016.
